Orchidectomy prior to definitive radiotherapy for localized prostatic cancer

International Journal of Radiation Oncology Biology Physics

Volumn 34, Issue 5, 1996, Pages 1045-1053

  Spry, Nigel A ^a   Meffan, Peter M ^b   Christie, David R H ^c   Morum, Pauline E ^d  

^a GEELONG HOSPITAL   (Australia)

^b NELSON HOSPITAL   (New Zealand)

^c WESTMEAD HOSPITAL   (Australia)

^d WELLINGTON HOSPITAL   (New Zealand)

Author keywords

Cytoreductive therapy; Localized prostatic cancer; Orchidectomy; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; TREATMENT OUTCOME;

EID: 0029995305     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(95)02385-2     Document Type: Article

References (40)

1. Akakura, K.; Bruchovsky, N.; Goldenberg, S. L.; Rennie, P. S.; Buckley, A. R.; Sullivan, L. D. Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen. Cancer 71:2782-2790; 1993.
2. Ang, K. K.; van der Schueen, E. The tolerance to multiple daily fractionated radiotherapy for the treatment of prostatic and bladder carcinoma: A feasibility study. Int. J. Radiat. Oncol. Biol. Phys. 8:1665-1670; 1982.
3. Bagshaw, M. A.; Kaplan, I. D.; Cox, R. C. Prostate cancer. Radiation therapy for localized disease. Cancer 71:939-952; 1993.
4. Beacock, C. J.; Buck, A. C.; Zwink, R.; Peeling, W. B.; Rees, R. W. M.; Turkes, A.; Walker, K.; Griffiths, K. The treatment of metastatic prostatic cancer with the slow release LH-RH analogue Zoladex ICI 118360. Br. J. Urol. 59:1-8; 1987.
5. Breslow, N. Covariance analysis of censored survival data. Biometrics 30:89-99; 1974.
6. Byar, D. P. The Veterans Adminstrative Cooperative Urological Research Group's studies of cancer of the prostate. Cancer 32:1126-1130; 1973.
7. Cox, D. R. Regression models and life-tables. J. B. Stat. Soc. B 34:187-220; 1972.
8. Crawford, E. D.; Eisenberger, M. A.; Mcleod, M. D.; Spaulding, J. T.; Dorr, F. A.; Blumenstein, B. A.; Davis, M. A.; Goodman, P. J. A controlled trial of Leuprolide with and without flutamide in prostatic carcinoma. N. Engl. J. Med. 321:419-424; 1989.
9. Fellows, G. J.; Clark, P. B.; Beynon, L. L.; Boreham, J.; Keen, C.; Parkinson, M. C.; Peto, R.; Webb, J. N. Treatment of advanced localised prostatic cancer by orchiectomy, radiotherapy, or combined treatment: A Medical Research Council study. Br. J. Urol. 70:304-309; 1992.
10. Green, N.; Bodner, H.; Broth, E.; Chiang, C.; Garrett, J.; Goldstein, A.; Goldberg, H. Improved control of bulky prostate carcinoma with sequential estrogen and radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 10:971-976; 1984.
11. Hanks, G. E. Optimising the radiation treatment and outcome of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 11:1235-1245; 1985.
12. Hanks, G. E. Radiotherapy or surgery for prostate cancer? Ten and fifteen-year results of external beam therapy. Acta Oncol. 230:231-237; 1991.
13. Hanks, G. E. Conformal radiation in prostate cancer: Reduced morbidity with hope of increased local control [editorial; comment]. Int. J. Radiat. Oncol. Biol. Phys. 25:377-378; 1993.
14. Hanks, G. E.; Daimond, J. J.; Krall, J. M.; Martz, K. L.; Kramer, S. A ten year follow up of 682 patients treated for prostate cancer with radiation therapy in the United States. Int. J. Radiat. Oncol. Biol. Phys. 13:499-505; 1987.
15. Harisiadis, L.; Veenema, R. J.; Senyszyn, J. J.; Purchner, P. J.; Tretter, P.; Romas, N. A.; Chang, C. H.; Lattimer, J. K.; Tannenbaum, M. Carcinoma of the prostate: Treatment with external radiotherapy. Cancer 41:2131-2142; 1978.
16. Isaacs, J. T. Relationship between tumor size and curability of prostate cancer by combined chemo-hormonal therapy in rats. Cancer Res. 49:6290-6294; 1989.
17. Iversen, P.; Rasmussen, F.; Klarskov, P.; Christensen, I. J. Long term results of Danish Prostatic Cancer Group trial 86. Cancer 72:3851-3854; 1993.
18. Keuppens, F.; Whelan, P.; Carneiro de Moura, J. L.; Newling, D.; Bono, A.; Denis, L.; Robinson, M.; Mahler, C.; Sylvester, R.; De Pauw, M.; et al. 7. Orchidectomy vs. Goserelin plus Flutamide in patients with metastatic prostate cancer (EORTC 30853). Cancer72:3863-3869; 1993.
19. Kuban, D. A.; El-Mahdi, A. M.; Schellhammer, P. F. Effect of local tumour control on distant metastasis and survival in prostatic adenocarcinoma. Urology 30:420-426; 1987.
20. Kumar, P. P.; Good, R. R.; Bartone, F. Iodine 125 interstitial irradiation for localized prostate cancer. JAMA 82:181-193; 1990.
21. Laramore, G. E.; Krall, J. M.; Thomas, F. J.; Russell, K. J.; Maor, M. H.; Hendrickson, F. R.; Martz, K. L.; Griffin, T. W.; Davis, L. W. Fast neutron radiotherapy for locally advanced prostate cancer. Final report of radiation therapy oncology group randomized clinical trial. Am. J. Clin. Oncol. 16:164-167; 1993.
22. Lepor, H.; Ross, A.; Walsh, P. C. The influence of hormonal therapy on survival of men with advanced prostatic cancer. J. Urol. 335-340; 1982.
23. Meffan, P. M.; Nacey, J. N. Ochiectomy and delayed radiotherapy as treatment for prostatic carcinoma. A 10 year survey. Br. J. Urol. 58:417-422; 1986.
24. Neglia, W. J.; Hussey, D. H.; Johnson, D. E. Megavoltage radiation therapy for carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 2:873-882; 1977.
25. Perez, C. A.; Garcia, D.; Simpson, J. R.; Zivnuska, F.; Lockett, M. A. Factors influencing outcome of definitive radiotherapy for localised carinoma of the prostate. Radiat. Oncol. 16:1-21; 1989.
26. Perez, C. A.; Hanks, G. E.; Leibel, S. A.; Zietman, A. L.; Fuks, Z.; Lee, W. R. Localized carcinoma of the prostate (stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy. Cancer 72:3156-3173; 1993.
27. Pilepich, M. D.; Krall, J.; George, F. W.; Asbell, S. O.; Plenk, H. D.; Johnson, M.; Stetz, J.; Zinninger, M.; Walz, B. J. Treatment related morbidity in phase III RTOG studies of extended field irradiation for carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 10:1861-1867; 1984.
28. Pilepich, M. V.; Krall, J.; Al-Sarraf, M.; Roach, M.; Doggett, R. L. S.; Sause, W.; Lawton, C. A.; Abrams, R. A.; Rotman, M.; Rubin, P.; Shipley, W. U.; Cox, J. D. A Phase III trial of androgen suppression before and during radiation therapy for locally advanced prostatic carcinoma: Preliminary report of RTOG protocol 8610. (Abstr.) Proc. Annu. Meet. Am. Soc. Clin. Oncol. 12:A703; 1993.
29. Pilepich, M. V.; Krall, J. M.; John, M. J.; Rubin, P.; Porter, A. T.; Marcial, V. A.; Martz, K. L. Hormonal cytoreduction in locally advanced carcinoma of the prostate treated with definitive radiotherapy: Preliminary results of RTOG 8307. Int. J. Radiat. Oncol. Biol. Phys. 16:813-817; 1989.
30. Porter, A. T.; Venner, P. M. The role of cytoreduction prior to definitive radiotherapy in locally advanced prostate cancer: The Canadian perspective. Prog. Clin. Biol. Res. 359:231-237; 1990.
31. Rosen, E.; cassady, J. R.; Connolly, J.; Chaffey, J. T. Radio-therapy for prostate carcinoma: The JCRT experience (1968-1978). II. Factors related to tumour control and complications. Int. J. Radiat. Oncol. Biol. Phys. 11:725-730; 1985.
32. Schellhammer, P. F.; El-Mahdi, A. M. Local failure and related complications after definitive treatment of carcinoma of the prostate by irradiation or surgery. Urol. Clin. Norm Am. 17:835-851; 1990.
33. Shearer, R. J.; Davies, J. H.; Gelister, J. S.; Dearnaley, D. Hormonal cytoreduction and radiotherapy for carcinoma of the prostate. Br. J. Urol. 69:521-524; 1992.
34. Soffen, E. M.; Hanks, G. E.; Hunt, M. A.; Epstein, B. E. Conformal static field radiation therapy treatment of early prostate cancer vs. nonconformal techniques: A reduction in acute morbidity. Int. J. Radiat. Oncol. Biol. Phys. 24:485-488; 1992.
35. Stamey, T. A.; Yang, N.; Hay, A. R. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med. 317:909; 1987.
36. Van der Werf-Messing, B.; Sourek-Zikova, V.; Blonk, D. I. Localised advanced carcinoma of the prostate. Radiation therapy vs. hormonal therapy. Int. J. Radiat. Oncol. Biol. Phys. 1:1043-1048; 1976.
37. Veterans Adminstration Cooperative Urological Research Group. Treatment and survival of patients with cancer of the prostate. Surg. Gynaecol. Obstet. 124:1011-1017; 1967.
38. Zagars, G. K.; Johnson, D. E.; von Eschenbach, A. C.; Hussey, D. H. Adjuvant estrogen following radiation therapy for stage C adenocarcinoma of the prostate: Long-term results of a prospective randomized study. Int. J. Radiat. Oncol. Biol. Phys. 14:1085-1091; 1988.
39. Zagars, G. K.; von Eschenbach, A. C.; Ayala, A. G.; Schultheiss, T. E.; Sherman, N. E. The influence of local control on metastatic dissemination of prostate cancer treated by external beam megavoltage radiation therapy. Cancer 68:2370-2377; 1991.
40. Zinke, H. Bilateral pelvic lymphadenectomy and radical prostatectomy for stage C or D adenocarcinoma of the prostate: Possible beneficial effects of adjuvant treatment. NCI Monogr. 7:109-115; 1988.